ZNF677 suppresses renal cell carcinoma progression through N6‐methyladenosine and transcriptional repression of CDKN3
Abstract Background Studies on biological functions of N6‐methyladenosine (m6A) modification in mRNA have sprung up in recent years. Previous studies have reported m6A can determine mRNA fate and play a pivotal role in tumour development and progression. The zinc finger protein 677 (ZNF677) belongs...
Main Authors: | Aolin Li, Congcong Cao, Ying Gan, Xiaofei Wang, Tianyu Wu, Quan Zhang, Yuchen Liu, Lin Yao, Qian Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.906 |
Similar Items
-
BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine
by: Fuming Qi, et al.
Published: (2022-12-01) -
Targeted Demethylation of the PLOD2 mRNA Inhibits the Proliferation and Migration of Renal Cell Carcinoma
by: Congcong Cao, et al.
Published: (2021-06-01) -
RETRACTED ARTICLE: Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1
by: Wuping Yang, et al.
Published: (2021-03-01) -
From DNA-protein interactions to the genetic circuit design using CRISPR-dCas systems
by: A. K. Shaytan, et al.
Published: (2022-12-01) -
Targeted Methylation of the LncRNA NEAT1 Suppresses Malignancy of Renal Cell Carcinoma
by: Jieqing Chen, et al.
Published: (2021-12-01)